Glenmark Pharmaceuticals has informed that it has attached media release on 24th May 2021, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe’ which is self?explanatory.
The above information is a part of company’s filings submitted to BSE.